In SLE, 30% of the patients have a preexisting complement deficiency (preferentially of C4, C2, and C1) (31), and deficiencies (preferentially of C5–C9 and properdin) are estimated to occur in up to 20% of individuals suffering from disseminated Neisseria infections. This evidence concerns the gene C2 and complement deficiency.